Cargando…
Clinically meaningful benefit: real world use compared against the American and European guidelines
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802502/ https://www.ncbi.nlm.nih.gov/pubmed/29238046 http://dx.doi.org/10.1038/s41408-017-0009-8 |
_version_ | 1783298531702865920 |
---|---|
author | Dreicer, Jessica J. Mailankody, Sham Fakhrejahani, Farhad Prasad, Vinay |
author_facet | Dreicer, Jessica J. Mailankody, Sham Fakhrejahani, Farhad Prasad, Vinay |
author_sort | Dreicer, Jessica J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5802502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58025022018-02-08 Clinically meaningful benefit: real world use compared against the American and European guidelines Dreicer, Jessica J. Mailankody, Sham Fakhrejahani, Farhad Prasad, Vinay Blood Cancer J Correspondence Nature Publishing Group UK 2017-12-14 /pmc/articles/PMC5802502/ /pubmed/29238046 http://dx.doi.org/10.1038/s41408-017-0009-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Dreicer, Jessica J. Mailankody, Sham Fakhrejahani, Farhad Prasad, Vinay Clinically meaningful benefit: real world use compared against the American and European guidelines |
title | Clinically meaningful benefit: real world use compared against the American and European guidelines |
title_full | Clinically meaningful benefit: real world use compared against the American and European guidelines |
title_fullStr | Clinically meaningful benefit: real world use compared against the American and European guidelines |
title_full_unstemmed | Clinically meaningful benefit: real world use compared against the American and European guidelines |
title_short | Clinically meaningful benefit: real world use compared against the American and European guidelines |
title_sort | clinically meaningful benefit: real world use compared against the american and european guidelines |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802502/ https://www.ncbi.nlm.nih.gov/pubmed/29238046 http://dx.doi.org/10.1038/s41408-017-0009-8 |
work_keys_str_mv | AT dreicerjessicaj clinicallymeaningfulbenefitrealworldusecomparedagainsttheamericanandeuropeanguidelines AT mailankodysham clinicallymeaningfulbenefitrealworldusecomparedagainsttheamericanandeuropeanguidelines AT fakhrejahanifarhad clinicallymeaningfulbenefitrealworldusecomparedagainsttheamericanandeuropeanguidelines AT prasadvinay clinicallymeaningfulbenefitrealworldusecomparedagainsttheamericanandeuropeanguidelines |